Eur Rev Med Pharmacol Sci 2014; 18 (10): 1473-1481

Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature

R. Taibi, A. Lleshi, L. Barzan, F. Fiorica, M. Leghissa, E. Vaccher, P. De Paoli, G. Franchin, M. Berretta, U. Tirelli

Department of Medical Oncology, CRO Aviano National Cancer Institute, Aviano, Italy. rostai@libero.it


Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and this number is growing. Recent improvements in cancer survival are largely due to earlier diagnosis and advancements in treatment. Despite having favorable effects on cancer survival, radiation therapy, surgery treatment and combination chemotherapy regimens can also cause long-term organ damage and functional disabilities.

In this paper we review the most important aspects of long-term toxicities in otolaryngology cancer survivors patients.

Free PDF Download

To cite this article

R. Taibi, A. Lleshi, L. Barzan, F. Fiorica, M. Leghissa, E. Vaccher, P. De Paoli, G. Franchin, M. Berretta, U. Tirelli
Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature

Eur Rev Med Pharmacol Sci
Year: 2014
Vol. 18 - N. 10
Pages: 1473-1481